258 related articles for article (PubMed ID: 22040826)
1. [Frontiers in vitamin D; basic research and clinical application. Eldecalcitol: the effect on bones and calcium metabolism].
Endo I; Matsumoto T
Clin Calcium; 2011 Nov; 21(11):103-10. PubMed ID: 22040826
[TBL] [Abstract][Full Text] [Related]
2. Eldecalcitol for the treatment of osteoporosis.
Matsumoto T; Endo I
Drugs Today (Barc); 2012 Mar; 48(3):189-96. PubMed ID: 22462038
[TBL] [Abstract][Full Text] [Related]
3. [Frontiers in vitamin D; Basic research and clinical application. Effect of eldecalcitol on bone structure].
Ito M
Clin Calcium; 2011 Nov; 21(11):119-25. PubMed ID: 22040828
[TBL] [Abstract][Full Text] [Related]
4. [Eldecalcitol (ED-71)].
Endo I; Matsumoto T
Clin Calcium; 2011 Jan; 21(1):53-8. PubMed ID: 21187594
[TBL] [Abstract][Full Text] [Related]
5. Eldecalcitol: newly developed active vitamin D(3) analog for the treatment of osteoporosis.
Hagino H
Expert Opin Pharmacother; 2013 Apr; 14(6):817-25. PubMed ID: 23477453
[TBL] [Abstract][Full Text] [Related]
6. [Frontiers in vitamin D; Basic research and clinical application. The effects of eldecalcitol on bone mineral density and fracture prevention--Post hoc analysis].
Hagino H
Clin Calcium; 2011 Nov; 21(11):111-8. PubMed ID: 22040827
[TBL] [Abstract][Full Text] [Related]
7. Eldecalcitol increases bone mineral density in Chinese osteoporotic patients without vitamin D or calcium supplementation.
Jiang Y; Tang H; Ma X; Cheng Q; Lin H; Jin X; Zhang Z; Yu W; He S; Kobayashi T; Uehara S; Matsumoto T; Xia W
J Bone Miner Metab; 2019 Nov; 37(6):1036-1047. PubMed ID: 31087185
[TBL] [Abstract][Full Text] [Related]
8. [Frontiers in vitamin D; basic research and clinical application. Inhibitory effects of eldecalcitol, an active vitamin D derivative, on bone resorption in vivo].
Harada S; Mizoguchi T; Takahashi N
Clin Calcium; 2011 Nov; 21(11):91-8. PubMed ID: 22040825
[TBL] [Abstract][Full Text] [Related]
9. Eldecalcitol: a review of its use in the treatment of osteoporosis.
Sanford M; McCormack PL
Drugs; 2011 Sep; 71(13):1755-70. PubMed ID: 21902297
[TBL] [Abstract][Full Text] [Related]
10. Eldecalcitol and calcitriol stimulates 'bone minimodeling,' focal bone formation without prior bone resorption, in rat trabecular bone.
Saito H; Takeda S; Amizuka N
J Steroid Biochem Mol Biol; 2013 Jul; 136():178-82. PubMed ID: 23069645
[TBL] [Abstract][Full Text] [Related]
11. A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind study.
Matsumoto T; Ito M; Hayashi Y; Hirota T; Tanigawara Y; Sone T; Fukunaga M; Shiraki M; Nakamura T
Bone; 2011 Oct; 49(4):605-12. PubMed ID: 21784190
[TBL] [Abstract][Full Text] [Related]
12. [Frontiers in vitamin D; basic research and clinical application. A review on histological findings in bones administered with eldecalcitol].
Hongo H; Sasaki M; Hasegawa T; Amizuka N
Clin Calcium; 2011 Nov; 21(11):63-70. PubMed ID: 22040822
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of eldecalcitol and alfacalcidol on bone and calcium metabolism.
Matsumoto T; Takano T; Yamakido S; Takahashi F; Tsuji N
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):261-4. PubMed ID: 20298784
[TBL] [Abstract][Full Text] [Related]
14. [Current Topics on Vitamin D. Treatment of osteoporosis with eldecalcitol: Its therapeutic efficacy and adverse effect on renal function].
Takeuchi Y
Clin Calcium; 2015 Mar; 25(3):425-32. PubMed ID: 25716816
[TBL] [Abstract][Full Text] [Related]
15. Eldecalcitol is superior to alfacalcidol in maintaining bone mineral density in glucocorticoid-induced osteoporosis patients (e-GLORIA).
Matsumoto T; Yamamoto K; Takeuchi T; Tanaka Y; Tanaka S; Nakano T; Ito M; Tomomitsu T; Hirakawa A; Soen S
J Bone Miner Metab; 2020 Jul; 38(4):522-532. PubMed ID: 32140784
[TBL] [Abstract][Full Text] [Related]
16. [Frontiers in vitamin D; basic Research and clinical application. Effect of active vitamin D3 on osteoporosis].
Yamauchi M; Sugimoto T
Clin Calcium; 2011 Nov; 21(11):17-24. PubMed ID: 22040817
[TBL] [Abstract][Full Text] [Related]
17. Eldecalcitol, a vitamin D analog, reduces bone turnover and increases trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
Smith SY; Doyle N; Boyer M; Chouinard L; Saito H
Bone; 2013 Nov; 57(1):116-22. PubMed ID: 23774444
[TBL] [Abstract][Full Text] [Related]
18. Treatment with the combination of ibandronate plus eldecalcitol has a synergistic effect on inhibition of bone resorption without suppressing bone formation in ovariectomized rats.
Sakai S; Takeda S; Sugimoto M; Shimizu M; Shimonaka Y; Yogo K; Hashimoto J; Bauss F; Endo K
Bone; 2015 Dec; 81():449-458. PubMed ID: 26281770
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the effect of eldecalcitol and serum 25(OH)D level.
Takano T; Kondo S; Saito H; Matsumoto T;
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():124-7. PubMed ID: 24240066
[TBL] [Abstract][Full Text] [Related]
20. Histological Effects of the Combined Administration of Eldecalcitol and a Parathyroid Hormone in the Metaphyseal Trabeculae of Ovariectomized Rats.
Hasegawa T; Yamamoto T; Sakai S; Miyamoto Y; Hongo H; Qiu Z; Abe M; Takeda S; Oda K; de Freitas PHL; Li M; Endo K; Amizuka N
J Histochem Cytochem; 2019 Mar; 67(3):169-184. PubMed ID: 30311820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
